Article Text

PDF
Biomarkers and heart disease
Effect of estimated glomerular filtration rate on plasma concentrations of B-type natriuretic peptides measured with multiple immunoassays in elderly individuals
  1. M Schou1,
  2. U Alehagen2,
  3. J P Goetze3,
  4. F Gustafsson4,
  5. U Dahlstrom2
  1. 1
    Department of Endocrinology and Cardiology, Hillerod University Hospital, DK-3400 Hillerod, Denmark
  2. 2
    Department of Cardiology, Linkobing University Hospital, Linkobing, Sweden
  3. 3
    Department of Clinical Chemistry, The Heart Centre, Rigshospitalet, DK-2100 Copenhagen, Denmark
  4. 4
    Department of Cardiology, The Heart Centre, Rigshospitalet, DK-2100 Copenhagen, Denmark
  1. Correspondence to Dr Morten Schou, Department of Cardiology and Endocrinology, Hillerod University Hospital, DK-3400 Hillerod, Denmark; m.schou{at}dadlnet.dk

Abstract

Objetive: This study was designed to quantify the crude and adjusted effects of estimated glomerular filtration rate (eGFR) on N-terminal-pro-brain-natriuretic peptide (proBNP) measured with three immunoassays and brain natriuretic peptide (BNP) in elderly individuals.

Design: Cross-sectional study.

Setting: 474 elderly outpatients with suspected heart failure (prevalence 13%) from the primary care.

Main outcome measures: The effects of eGFR on proBNP, measured with three different immunoassays (Roche Diagnostics, Oslo and Copenhagen), and BNP (Shionogi) concentrations were evaluated by multiple linear regression models.

Results: In univariate analyses the effect of a 10% decrease in eGFR on proBNP concentrations was a 15% (95% confidence interval 11% to 18%), 9% (5% to 13%) and 21% (14% to 28%) increase. In multivariate models the effect was a 7% (3% to 11%), 4% (2% to 6%) and 13% (4% to 20%) increase. The effect of a 10% decrease in eGFR on BNP concentrations (Shionogi) was a 10% (5% to 15%) (univariate) and a 4% (1% to 9%) (multivariate) increase.

Conclusions: The effect of eGFR on proBNP measured with three different immunoassays and BNP is modest and within the same range. The effect of eGFR on proBNP and BNP concentrations is reduced substantially after adjustment for important clinical and echocardiographic confounders. These findings should be considered before renal function is offered as an explanation for increased proBNP or BNP levels.

Statistics from Altmetric.com

Footnotes

  • Funding The study was supported by grants from the County Council of Ostergotland, the Swedish Heart and Lung foundation, and the Linkoping University Research Foundation CIRC.

  • Competing interests MS and FG are members of the steering committee of the NorthStar study that is supported by Roche Diagnostics International, Basel with unrestricted grants.

  • Provenance and peer review Not commissioned; externally peer reviewed.

Request permissions

If you wish to reuse any or all of this article please use the link below which will take you to the Copyright Clearance Center’s RightsLink service. You will be able to get a quick price and instant permission to reuse the content in many different ways.